ARCHIVES

NCI Awards $59M Contract For Key Project To consolidate Phase III Trial Administration

This article is from The Cancer Letter archive.

Vol. 25 No. 41 | October 29, 1999

Download PDF Visit The Full Archive

Related Articles

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

March 12, 2010

Beta Blockers Negate Harmful Recurrence Risks of ACE Inhibitors

April 29, 2011

New Research Grant Awards

October 18, 1974

Low-Dose IFN Not Effective Against Melanoma, Study Finds

December 26, 2003

In Brief: NCCS to hold Candlelight Vigil Sept. 25; Moffit Wins Chemistry-Biology Grants

September 17, 1999

In Brief: NCI Scientists May Run For Congress; Upton Back Heroin For Terminal Cancer Patients

September 9, 1977